.svg){kind=small}
Dec-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Alberta, Dosecann has shown a stable performance in the Capsules category, maintaining its position within the top 10 for the last four months of 2024. However, there was a slight dip in October, where it dropped to 11th place before recovering to 9th in November and December. This consistency suggests a solid consumer base for their capsules. In the Oil category, Dosecann experienced a more dynamic movement, peaking at 8th place in October, which indicates a strong month-over-month sales increase before settling back to 9th place in subsequent months. This fluctuation highlights the potential volatility in consumer preferences or supply chain factors affecting sales.
Meanwhile, in Ontario, Dosecann has maintained a consistent ranking in the Topical category, holding steady at the 4th position throughout the last quarter of 2024. This stability in a competitive market like Ontario underscores the brand's strong foothold in this category. However, the Vapor Pens category tells a different story, where Dosecann did not make it into the top 30, showing a ranking of 89th in September and slipping to 96th by December. This indicates a significant challenge in gaining traction within this segment, possibly due to intense competition or differing consumer preferences. In British Columbia, the Capsules category saw Dosecann drop from 5th to 7th place in November before rebounding to 6th in December, suggesting some variability in consumer demand or market conditions.
Competitive Landscape
In the Ontario capsules market, Dosecann has experienced fluctuating rankings over the last few months, indicating a dynamic competitive landscape. Despite a slight dip in October 2024, where Dosecann fell to 8th place, it regained its 7th position by December 2024. This recovery is notable, especially considering the consistent upward trajectory of Indiva, which climbed from 8th to 5th place, and Stigma Grow, which improved from 10th to 8th place. Meanwhile, Emprise Canada maintained a strong presence, fluctuating between 5th and 6th place. The competitive pressure from these brands, particularly Indiva's and Stigma Grow's sales growth, suggests that Dosecann needs to strategize effectively to enhance its market share and stabilize its rank amidst these rising competitors.
Notable Products
In December 2024, the top-performing product for Dosecann was CBD 50 Capsules 30-Pack (1500mg CBD) in the Capsules category, maintaining its first place position consistently since September 2024 with sales of 3363 units. The CBD/THC Daily Relief Cream in the Topical category rose to second place, recovering from a dip in November. CBD Oil (30ml) held steady in third place, although its sales decreased slightly compared to previous months. CBD Capsules 30-Pack (750mg CBD) remained fourth, showing a notable increase in sales since September. The Indica Blackberry Cream Distillate Disposable Pen stayed at fifth position, with sales figures remaining relatively stable throughout the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
